Cargando…
Current progress in antiviral strategies
The prevalence of chronic viral infectious diseases, such as human immunodeficiency virus (HIV), hepatitis C virus (HCV), and influenza virus; the emergence and re-emergence of new viral infections, such as picornaviruses and coronaviruses; and, particularly, resistance to currently used antiviral d...
Autores principales: | Lou, Zhiyong, Sun, Yuna, Rao, Zihe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112804/ https://www.ncbi.nlm.nih.gov/pubmed/24439476 http://dx.doi.org/10.1016/j.tips.2013.11.006 |
Ejemplares similares
-
A comprehensive procedure for antiviral inhibitor discovery using EV71 as an example
por: Cao, Lin, et al.
Publicado: (2015) -
Erratum to: A comprehensive procedure for antiviral inhibitor discovery using EV71 as an example
por: Cao, Lin, et al.
Publicado: (2016) -
Molecular mechanism of SCARB2-mediated attachment and uncoating of EV71
por: Dang, Minghao, et al.
Publicado: (2014) -
Identification of serotonin 2A receptor as a novel HCV entry factor by a chemical biology strategy
por: Cao, Lin, et al.
Publicado: (2018) -
The newly emerged SARS-Like coronavirus HCoV-EMC also has an “Achilles’ heel”: current effective inhibitor targeting a 3C-like protease
por: Ren, Zhilin, et al.
Publicado: (2013)